Keywords: cortech, starts, phase, ii, study, started, its

CORTECH STARTS PHASE II STUDY

Article | 01 March 1993

- Cortech has started a Phase II study of its bradykinin antagonist, Bradycor, in patents with system inflammatory response syndrome and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in